<?xml version="1.0" encoding="UTF-8"?>
<ProteinModifications>
	<Entry>
		<Id>0001</Id>
		<Description>a protein modification that effectively forms a O3-xylosylserine.</Description>
		<SystematicName>(S)-2-amino-3-(alpha-D-xylopyranosyloxy)propanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0406</Id>
			<Name>O-xylosyl-L-serine</Name>
			<Status>deprecated</Status>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00814</Id>
			<Name>O-xylosyl-L-serine</Name>
		</CrossReference>
		<Formula>C 8 H 13 N 1 O 6</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">SER</Id>
			</Component>
			<Component type="Ligand" label="2">
				<Id source="PDBCC">XYS</Id>
			</Component>
			<Bond>
				<Atom component="1">OG</Atom>
				<Atom component="2">C1</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry>
	<Entry>
		<Id>0002</Id>
		<Description>A protein modification that effectively converts an L-asparagine residue to an N4-glycosyl-L-asparagine.</Description>
		<SystematicName>(S)-2-amino-4-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)amino-4-oxobutanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0151</Id>
			<Name>N4-(N-acetylamino)glucosyl-L-asparagine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00160</Id>
			<Name>N4-glycosyl-L-asparagine</Name>
		</CrossReference>
		<Formula>C 12 H 19 N 3 O 7</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">ASN</Id>
			</Component>			
			<Component type="Ligand" label="2">
				<Id source="PDBCC">NAG</Id>
			</Component>
			<Bond>
				<Atom component="1">ND2</Atom>
				<Atom component="2">C1</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry>
	<Entry>
		<Id>0003</Id>
		<Description>A protein modification that effectively converts an L-cysteine residue to S-phospho-L-cysteine.</Description>
		<SystematicName>(R)-2-amino-3-(phosphonosulfanyl)propanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>CSP</Id>
			<Name>S-PHOSPHOCYSTEINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0034</Id>
			<Name>S-phospho-L-cysteine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00043</Id>
			<Name>S-phospho-L-cysteine</Name>
		</CrossReference>
		<Formula>C 3 H 6 N 1 O 4 P 1 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CSP</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0004</Id>
		<Description>A protein modification that effectively converts an L-histidine residue to tele-phospho-L-histidine (Ntau-phospho-L-histidine, 1'-phospho-L-histidine).</Description>
		<SystematicName>(S)-2-amino-3-(1-phosphono-1H-imidazol-4-yl)propanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>NEP</Id>
			<Name>N1-PHOSPHONOHISTIDINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0035</Id>
			<Name>1'-phospho-L-histidine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00044</Id>
			<Name>1'-phospho-L-histidine</Name>
		</CrossReference>
		<Formula>C 3 H 6 N 1 O 4 P 1 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">NEP</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0005</Id>
		<Description>A protein modification that effectively converts an L-histidine residue to pros-phospho-L-histidine (Npi-phospho-L-histidine, 3'-phospho-L-histidine).</Description>
		<SystematicName>(S)-2-amino-3-(3-phosphono-3H-imidazol-4-yl)propanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>HIP</Id>
			<Name>ND1-PHOSPHONOHISTIDINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0036</Id>
			<Name>3'-phospho-L-histidine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00045</Id>
			<Name>3'-phospho-L-histidine</Name>
		</CrossReference>
		<Formula>C 6 H 8 N 3 O 4 P 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">HIP</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0006</Id>
		<Description>A protein modification that effectively converts an L-serine residue to O-phospho-L-serine.</Description>
		<SystematicName>(S)-2-amino-3-(phosphonooxy)propanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>SEP</Id>
			<Name>PHOSPHOSERINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0037</Id>
			<Name>O-phospho-L-serine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00046</Id>
			<Name>O-phospho-L-serine</Name>
		</CrossReference>
		<Formula>C 3 H 6 N 1 O 5 P 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">SEP</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0007</Id>
		<Description>A protein modification that effectively converts an L-threonine residue to O-phospho-L-threonine.</Description>
		<SystematicName>(2S,3R)-2-amino-3-phosphonooxybutanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>TPO</Id>
			<Name>PHOSPHOTHREONINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0038</Id>
			<Name>O-phospho-L-threonine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00047</Id>
			<Name>O-phospho-L-threonine</Name>
		</CrossReference>
		<Formula>C 4 H 8 N 1 O 5 P 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">TPO</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0008</Id>
		<Description>A protein modification that effectively converts an L-tyrosine residue to O4'-phospho-L-tyrosine.</Description>
		<SystematicName>(2S)-2-amino-3-(4-phosphonooxyphenyl)propanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>PTR</Id>
			<Name>O-PHOSPHOTYROSINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0039</Id>
			<Name>O4'-phospho-L-tyrosine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00048</Id>
			<Name>O4'-phospho-L-tyrosine</Name>
		</CrossReference>
		<Formula>C 9 H 10 N 1 O 5 P 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">PTR</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<!--Entry>
		<Id>0009</Id>
		<Description>A protein modification that effectively converts an L-glutamine residue to N-acetyl-L-glutamine.</Description>
		<SystematicName>(S)-2-acetamido-5-pentanediamic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0045</Id>
			<Name>N-acetyl-L-glutamine</Name>
			<Status>deprecated</Status>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00054</Id>
			<Name>N-acetyl-L-glutamine</Name>
		</CrossReference>
		<Formula>C 7 H 11 N 2 O 3</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">GLN</Id>
				<Terminal>N</Terminal>
			</Component>
			<Component type="Ligand" label="2">
				<Id source="PDBCC">ACE</Id>
			</Component>
			<Bond>
				<Atom component="1">N</Atom>
				<Atom component="2">C</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry>
	<Entry>
		<Id>0010</Id>
		<Description>A protein modification that effectively converts an L-methionine to N-acetyl-L-methionine.</Description>
		<SystematicName>(2S)-2-acetamido-4-(methylsulfanyl)butanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0049</Id>
			<Name>N-acetyl-L-methionine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00058</Id>
			<Name>N-acetyl-L-methionine</Name>
		</CrossReference>
		<Formula>C 7 H 12 N 1 O 2 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">MET</Id>
				<Terminal>N</Terminal>
			</Component>
			<Component type="Ligand" label="2">
				<Id source="PDBCC">ACE</Id>
			</Component>
			<Bond>
				<Atom component="1">N</Atom>
				<Atom component="2">C</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry-->
	<Entry>
		<Id>0011</Id>
		<Description>A protein modification that effectively converts an L-lysine residue to N6-acetyl-L-lysine.</Description>
		<SystematicName>(2S)-2-amino-6-acetamidohexanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>ALY</Id>
			<Name>N(6)-ACETYLLYSINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0055</Id>
			<Name>N6-acetyl-L-lysine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00064</Id>
			<Name>N6-acetyl-L-lysine</Name>
		</CrossReference>
		<Formula>C 8 H 14 N 2 O 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">ALY</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0012</Id>
		<Description>A protein modification that effectively converts an L-tyrosine residue to O4'-sulfo-L-tyrosine.</Description>
		<SystematicName>(S)-2-amino-3-(4-sulfooxyphenyl)propanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>TYS</Id>
			<Name>O-SULFO-L-TYROSINE </Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0172</Id>
			<Name>O4'-sulfo-L-tyrosine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00181</Id>
			<Name>O4'-sulfo-L-tyrosine</Name>
		</CrossReference>
		<Formula>C 9 H 9 N 1 O 5 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">TYS</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0013</Id>
		<Description>A protein modification that effectively converts an L-lysine residue to N6-methyl-L-lysine.</Description>
		<SystematicName>(S)-2-amino-6-methylaminohexanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>MLZ</Id>
			<Name>N-METHYL-LYSINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0076</Id>
			<Name>N6-methyl-L-lysine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00085</Id>
			<Name>N6-methyl-L-lysine</Name>
		</CrossReference>
		<Formula>C 7 H 14 N 2 O 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">MLZ</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0014</Id>
		<Description>A protein modification that effectively converts an L-arginine residue to 5-methyl-L-arginine.</Description>
		<SystematicName>(2S,5S)-2-amino-5-carbamimidamidohexanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>AGM</Id>
			<Name>5-METHYL-ARGININE </Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0272</Id>
			<Name>5-methyl-L-arginine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00277</Id>
			<Name>5-methyl-L-arginine</Name>
		</CrossReference>
		<Formula>C 7 H 14 N 4 O 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">AGM</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0015</Id>
		<Description>A protein modification that effectively converts an L-lysine residue to N6,N6,N6-trimethyl-L-lysine.</Description>
		<SystematicName>(5S)-5-amino-5-carboxy-N,N,N-trimethylpentan-1-aminium</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>M3L</Id>
			<Name>N-TRIMETHYLLYSINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0074</Id>
			<Name>N6,N6,N6-trimethyl-L-lysine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00083</Id>
			<Name>N6,N6,N6-trimethyl-L-lysine</Name>
		</CrossReference>
		<Formula>C 9 H 19 N 2 O 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">M3L</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0016</Id>
		<Description>A protein modification that effectively converts an L-methionine residue to N-methyl-L-methionine.</Description>
		<SystematicName>(S)-2-methylamino-4-(methylsulfanyl)butanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>MME</Id>
			<Name>N-METHYL METHIONINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0064</Id>
			<Name>N-methyl-L-methionine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00073</Id>
			<Name>N-methyl-L-methionine</Name>
		</CrossReference>
		<Formula>C 6 H 11 N 1 O 1 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">MME</Id>
				<Terminal>N</Terminal>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0017</Id>
		<Description>A protein modification that effectively converts an L-proline residue to 4-hydroxy-L-proline.</Description>
		<SystematicName>(2S,4R)-4-hydroxypyrrolidine-2-carboxylic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>HYP</Id>
			<Name>4-HYDROXYPROLINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0030</Id>
			<Name>4-hydroxy-L-proline</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00039</Id>
			<Name>4-hydroxy-L-proline</Name>
		</CrossReference>
		<Formula>C 5 H 7 N 1 O 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">HYP</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0018</Id>
		<Description>A protein modification that effectively cross-links two L-cysteine residues to form L-cystine.</Description>
		<SystematicName>(R,R)-3,3'-disulfane-1,2-diylbis(2-aminopropanoic acid)</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0025</Id>
			<Name>L-cystine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00034</Id>
			<Name>L-cystine (cross-link)</Name>
		</CrossReference>
		<Formula>C 6 H 8 N 2 O 2 S 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Bond>
				<Atom component="1">SG</Atom>
				<Atom component="2">SG</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink2</Category>
	</Entry>
	<Entry>
		<Id>0019</Id>
		<Description>A protein modification that effectively converts an L-cysteine residue to L-cysteine methyl disulfide.</Description>
		<SystematicName>(R)-2-amino-3-(methyldisulfanediyl)propanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>SCH</Id>
			<Name>S-METHYL-THIO-CYSTEINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0101</Id>
			<Name>L-cysteine methyl disulfide</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00110</Id>
			<Name>L-cysteine methyl disulfide</Name>
		</CrossReference>
		<Formula>C 4 H 7 N 1 O 1 S 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">SCH</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0020</Id>
		<Description>A protein modification that effectively converts three L-cysteine residues and a three-iron four-sulfur cluster to tris-L-cysteinyl triiron tetrasulfide.</Description>
		<SystematicName>mu3-sulfido-tri-mu-sulfidotris(cysteinato-kappaS-iron)</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0139</Id>
			<Name>tris-L-cysteinyl triiron tetrasulfide</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00148</Id>
			<Name>tris-L-cysteinyl triiron tetrasulfide</Name>
		</CrossReference>
		<Formula>C 9 Fe 3 H 12 N 3 O 3 S 7</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="3">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="Ligand" label="4">
				<Id source="PDBCC">F3S</Id>
			</Component>
			<Bond>
				<Atom component="1">SG</Atom>
				<Atom component="4">FE1</Atom>
			</Bond>
			<Bond>
				<Atom component="2">SG</Atom>
				<Atom component="4">FE3</Atom>
			</Bond>
			<Bond>
				<Atom component="3">SG</Atom>
				<Atom component="4">FE4</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink3</Category>
	</Entry>
	<Entry>
		<Id>0021</Id>
		<Description>A protein modification that effectively converts four L-cysteine residues and a two-iron two-sulfur cluster to tetrakis-L-cysteinyl diiron disulfide.</Description>
		<SystematicName>tetrakis(cysteinato)-1kappaS,1kappaS,2kappaS,2kappaS-di-mu-sulfidodiiron</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0137</Id>
			<Name>tetrakis-L-cysteinyl diiron disulfide</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00146</Id>
			<Name>tetrakis-L-cysteinyl diiron disulfide</Name>
		</CrossReference>
		<Formula>C 12 Fe 2 H 16 N 4 O 4 S 6</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="3">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="4">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="Ligand" label="5">
				<Id source="PDBCC">FES</Id>
			</Component>
			<Bond>
				<Atom component="1">SG</Atom>
				<Atom component="5">FE1</Atom>
			</Bond>
			<Bond>
				<Atom component="2">SG</Atom>
				<Atom component="5">FE1</Atom>
			</Bond>
			<Bond>
				<Atom component="3">SG</Atom>
				<Atom component="5">FE2</Atom>
			</Bond>
			<Bond>
				<Atom component="4">SG</Atom>
				<Atom component="5">FE2</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink4</Category>
	</Entry>
	<Entry>
		<Id>0022</Id>
		<Description>A protein modification that effectively converts a source amino acid residue to an N-formyl-L-methionine, a natural pretranslational modification.</Description>
		<SystematicName>(S)-2-formylamino-4-(methylsulfanyl)butanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>FME</Id>
			<Name>N-FORMYLMETHIONINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0021</Id>
			<Name>N-formyl-L-methionine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00030</Id>
			<Name>N-formyl-L-methionine</Name>
		</CrossReference>
		<Formula>C 6 H 10 N 1 O 2 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">FME</Id>
				<Terminal>N</Terminal>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0023</Id>
		<Description>A protein modification that effectively converts a source amino acid residue to an L-selenocysteine, a natural pretranslational modification.</Description>
		<SystematicName>(R)-2-amino-3-selanylpropanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>CSE</Id>
			<Name>SELENOCYSTEINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0022</Id>
			<Name>L-selenocysteine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00031</Id>
			<Name>L-selenocysteine residue</Name>
		</CrossReference>
		<Formula>C 6 H 10 N 1 O 2 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CSE</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0024</Id>
		<Description>A protein modification that effectively converts an L-asparagine residue to (2S,3R)-3-hydroxyasparagine.</Description>
		<SystematicName>(2S,3R)-2-amino-3-hydroxy-4-butanediamic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>AHB</Id>
			<Name>BETA-HYDROXYASPARAGINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0026</Id>
			<Name>(2S,3R)-3-hydroxyasparagine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00035</Id>
			<Name>(2S,3R)-3-hydroxyasparagine</Name>
		</CrossReference>
		<Formula>C 4 H 6 N 2 O 3</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">AHB</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0025</Id>
		<Description>A protein modification that effectively converts an L-aspartic acid residue to (2S,3R)-3-hydroxyaspartic acid.</Description>
		<SystematicName>(2S,3R)-2-amino-3-hydroxybutanedioic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>BHD</Id>
			<Name>BETA-HYDROXYASPARTIC ACID</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0027</Id>
			<Name>(2S,3R)-3-hydroxyaspartic acid</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00036</Id>
			<Name>(2S,3R)-3-hydroxyaspartic acid</Name>
		</CrossReference>
		<Formula>C 4 H 5 N 1 O 4</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">BHD</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0026</Id>
		<Description>A protein modification that effectively converts an L-lysine residue to 5-hydroxy-L-lysine.</Description>
		<SystematicName>(2S,5R)-2,6-diamino-5-hydroxyhexanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>LYZ</Id>
			<Name>5-HYDROXYLYSINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0028</Id>
			<Name>5-hydroxy-L-lysine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00037</Id>
			<Name>5-hydroxy-L-lysine</Name>
		</CrossReference>
		<Formula>C 6 H 12 N 2 O 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">LYZ</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0027</Id>
		<Description>A protein modification that effectively converts an L-proline residue to 3-hydroxy-L-proline.</Description>
		<SystematicName>(2S,3S)-3-hydroxypyrrolidine-2-carboxylic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>HY3</Id>
			<Name>3-HYDROXYPROLINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0029</Id>
			<Name>3-hydroxy-L-proline</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00038</Id>
			<Name>3-hydroxy-L-proline</Name>
		</CrossReference>
		<Formula>C 5 H 7 N 1 O 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">HY3</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0028</Id>
		<Description>A protein modification that effectively converts an L-glutamine residue to 2-pyrrolidone-5-carboxylic acid.</Description>
		<SystematicName>(S)-5-oxo-2-pyrrolidinecarboxylic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>PCA</Id>
			<Name>PYROGLUTAMIC ACID</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0031</Id>
			<Name>2-pyrrolidone-5-carboxylic acid</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00040</Id>
			<Name>2-pyrrolidone-5-carboxylic acid (Gln)</Name>
		</CrossReference>
		<Formula>C 5 H 6 N 1 O 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">PCA</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0029</Id>
		<Description>A protein modification that effectively converts an L-glutamic acid residue to L-gamma-carboxyglutamic acid.</Description>
		<SystematicName>(S)-3-amino-1,1,3-propanetricarboxylic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>CGU</Id>
			<Name>GAMMA-CARBOXY-GLUTAMIC ACID</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0032</Id>
			<Name>L-gamma-carboxyglutamic acid</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00041</Id>
			<Name>L-gamma-carboxyglutamic acid</Name>
		</CrossReference>
		<Formula>C 6 H 7 N 1 O 5</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CGU</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0030</Id>
		<Description>A protein modification that effectively converts an L-aspartic acid residue to L-aspartic 4-phosphoric anhydride.</Description>
		<SystematicName>(2S)-2-amino-4-oxo-4-(phosphonooxy)butanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>PHD</Id>
			<Name>ASPARTYL PHOSPHATE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0033</Id>
			<Name>L-aspartic 4-phosphoric anhydride</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00042</Id>
			<Name>L-aspartic 4-phosphoric anhydride</Name>
		</CrossReference>
		<Formula>C 4 H 6 N 1 O 6 P 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">PHD</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0031</Id>
		<Description>A protein modification that effectively converts an L-histidine residue to diphthamide.</Description>
		<SystematicName>(2R)-1-amino-4-(4-[(2S)-2-amino-2-carboxyethyl]-1H-imidazol-2-yl)-N,N,N-trimethyl-1-oxobutan-2-aminium</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>DDE</Id>
			<Name>{3-[4-(2-AMINO-2-CARBOXY-ETHYL)-1H-IMIDAZOL-2-YL]-1-CARBAMOYL-PROPYL}-TRIMETHYL-AMMONIUM</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0040</Id>
			<Name>2'-[3-carboxamido-3-(trimethylammonio)propyl]-L-histidine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00049</Id>
			<Name>2'-[3-carboxamido-3-(trimethylammonio)propyl]-L-histidine</Name>
		</CrossReference>
		<Formula>C 13 H 22 N 5 O 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">DDE</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0032</Id>
		<Description>A protein modification that effectively converts an L-cysteine residue to S-acetyl-L-cysteine.</Description>
		<SystematicName>(R)-2-amino-3-(acetylsulfanyl)propanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>SCY</Id>
			<Name>S-ACETYL-CYSTEINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0056</Id>
			<Name>S-acetyl-L-cysteine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00065</Id>
			<Name>S-acetyl-L-cysteine</Name>
		</CrossReference>
		<Formula>C 5 H 7 N 1 O 2 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">SCY</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0033</Id>
		<Description>A protein modification that effectively converts a glycine residue to N-myristoylglycine.</Description>
		<SystematicName>(tetradecanoylamino)ethanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0059</Id>
			<Name>N-myristoyl-glycine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00068</Id>
			<Name>N-myristoylglycine</Name>
		</CrossReference>
		<Formula>C 16 H 30 N 1 O 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">GLY</Id>
			</Component>
			<Component type="Ligand" label="2">
				<Id source="PDBCC">MYR</Id>
			</Component>
			<Bond>
				<Atom component="1">N</Atom>
				<Atom component="2">C1</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry>
	<Entry>
		<Id>0034</Id>
		<Description>A protein modification that effectively converts an L-alanine residue to N-methyl-L-alanine.</Description>
		<SystematicName>(S)-2-methylaminopropanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>MAA</Id>
			<Name>N-methyl-L-alanine</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0061</Id>
			<Name>N-methyl-L-alanine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00070</Id>
			<Name>N-methyl-L-alanine</Name>
		</CrossReference>
		<Formula>C 4 H 7 N 1 O 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">MAA</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0035</Id>
		<Description>A protein modification that effectively converts an L-phenylalanine residue to N-methyl-L-phenylalanine.</Description>
		<SystematicName>(S)-2-methylamino-3-phenylpropanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>MEA</Id>
			<Name>N-METHYLPHENYLALANINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0065</Id>
			<Name>N-methyl-L-phenylalanine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00074</Id>
			<Name>N-methyl-L-phenylalanine</Name>
		</CrossReference>
		<Formula>C 10 H 11 N 1 O 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">MEA</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<!--Entry>
		<Id>0036</Id>
		<Description>A protein modification that effectively converts an L-proline residue to N,N-dimethyl-L-proline.</Description>
		<SystematicName>(S)-2-carboxy-1,1-dimethylpyrrolidinium</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0066</Id>
			<Name>N,N-dimethyl-L-proline</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00075</Id>
			<Name>N,N-dimethyl-L-proline</Name>
		</CrossReference>
		<Formula>C 7 H 13 N 1 O 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">PRO</Id>
			</Component>
			<Component type="Ligand" label="2">
				<Id source="PDBCC">PBE</Id>
			</Component>
			<Bond>
				<Atom component="1"></Atom>
				<Atom component="2"></Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry-->
	<Entry>
		<Id>0037</Id>
		<Description>A protein modification that effectively converts an L-arginine residue to N(omega),N'(omega)-dimethyl-L-arginine.</Description>
		<SystematicName>(S)-2-amino-5-[((methylamino)(methylimino)methyl)amino]pentanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>2MR</Id>
			<Name>N3, N4-DIMETHYLARGININE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0067</Id>
			<Name>omega-N,omega-N'-dimethyl-L-arginine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00076</Id>
			<Name>omega-N,omega-N'-dimethyl-L-arginine</Name>
		</CrossReference>
		<Formula>C 8 H 16 N 4 O 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">2MR</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0038</Id>
		<Description>A protein modification that effectively converts an L-arginine residue to N(omega),N(omega)-dimethyl-L-arginine.</Description>
		<SystematicName>(S)-2-amino-5-([(dimethylamino)(imino)methyl]amino)pentanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>DA2</Id>
			<Name>NG,NG-DIMETHYL-L-ARGININE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0068</Id>
			<Name>omega-N,omega-N-dimethyl-L-arginine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00077</Id>
			<Name>omega-N,omega-N-dimethyl-L-arginine</Name>
		</CrossReference>
		<Formula>C 8 H 16 N 4 O 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">DA2</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0039</Id>
		<Description>A protein modification that effectively converts an L-asparagine residue to N4-methyl-L-asparagine.</Description>
		<SystematicName>(S)-2-amino-N4-methylbutanediamic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>MEN</Id>
			<Name>N-METHYL ASPARAGINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0070</Id>
			<Name>N4-methyl-L-asparagine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00079</Id>
			<Name>N4-methyl-L-asparagine</Name>
		</CrossReference>
		<Formula>C 5 H 8 N 2 O 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">MEN</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0040</Id>
		<Description>A protein modification that effectively converts an L-glutamine residue to N5-methyl-L-glutamine.</Description>
		<SystematicName>(2S)-2-amino-5-methylamino-5-oxopentanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>MEQ</Id>
			<Name>N5-METHYLGLUTAMINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0071</Id>
			<Name>N5-methyl-L-glutamine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00080</Id>
			<Name>N5-methyl-L-glutamine</Name>
		</CrossReference>
		<Formula>C 6 H 10 N 2 O 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">MEQ</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0041</Id>
		<Description>A protein modification that effectively converts an L-histidine residue to pros-methyl-L-histidine (N-pi-methyl-L-histidine, 3'-methyl-L-histidine).</Description>
		<SystematicName>(S)-2-amino-3-(3-methyl-3H-imidazol-4-yl)propanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>MHS</Id>
			<Name>N1-METHYLATED HISTIDINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0073</Id>
			<Name>3'-methyl-L-histidine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00082</Id>
			<Name>3'-methyl-L-histidine</Name>
		</CrossReference>
		<Formula>C 7 H 9 N 3 O 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">MHS</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0042</Id>
		<Description>A protein modification that effectively converts an L-lysine residue to N6,N6-dimethyl-L-lysine.</Description>
		<SystematicName>(S)-2-amino-6-dimethylaminohexanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>MLY</Id>
			<Name>N-DIMETHYL-LYSINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0075</Id>
			<Name>N6,N6-dimethyl-L-lysine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00084</Id>
			<Name>N6,N6-dimethyl-L-lysine</Name>
		</CrossReference>
		<Formula>C 8 H 16 N 2 O 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">MLY</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0043</Id>
		<Description>A protein modification that effectively converts an L-arginine residue to L-arginine amide.</Description>
		<SystematicName>(S)-2-amino-5-carbamimidamidopentanamide</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>AAR</Id>
			<Name>ARGININEAMIDE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0082</Id>
			<Name>L-arginine amide</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00091</Id>
			<Name>L-arginine amide</Name>
		</CrossReference>
		<Formula>C 6 H 14 N 5 O 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">AAR</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0044</Id>
		<Description>A protein modification that effectively converts an L-cysteine residue to L-cysteine amide.</Description>
		<SystematicName>(R)-2-amino-3-sulfanylpropanamide</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>CY3</Id>
			<Name>2-AMINO-3-MERCAPTO-PROPIONAMIDE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0085</Id>
			<Name>L-cysteine amide</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00094</Id>
			<Name>L-cysteine amide</Name>
		</CrossReference>
		<Formula>C 3 H 7 N 2 O 1 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CY3</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0045</Id>
		<Description>A protein modification that effectively converts an L-leucine residue to L-leucine amide.</Description>
		<SystematicName>(S)-2-amino-4-methylpentanamide</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>CLE</Id>
			<Name>LEUCINE AMIDE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0091</Id>
			<Name>L-leucine amide</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00100</Id>
			<Name>L-leucine amide</Name>
		</CrossReference>
		<Formula>C 6 H 13 N 2 O 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CLE</Id>
				<Terminal>C</Terminal>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0046</Id>
		<Description>A protein modification that effectively converts an L-phenylalanine residue to L-phenylalanine amide.</Description>
		<SystematicName>(S)-2-amino-3-phenylpropanamide</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>NFA</Id>
			<Name>PHENYLALANINE AMIDE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0094</Id>
			<Name>L-phenylalanine amide</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00103</Id>
			<Name>L-phenylalanine amide</Name>
		</CrossReference>
		<Formula>C 9 H 11 N 2 O 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">NFA</Id>
				<Terminal>C</Terminal>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0047</Id>
		<Description>A protein modification that effectively converts an L-proline residue to L-proline amide.</Description>
		<SystematicName>(S)-pyrrolidine-2-carboxamide</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>LPD</Id>
			<Name>L-PROLINAMIDE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0095</Id>
			<Name>L-proline amide</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00104</Id>
			<Name>L-proline amide</Name>
		</CrossReference>
		<Formula>C 5 H 9 N 2 O 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">LPD</Id>
				<Terminal>C</Terminal>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<!--Entry>
		<Id>0048</Id>
		<Description>A protein modification that effectively converts an L-tyrosine residue to L-tyrosine amide.</Description>
		<SystematicName>(S)-2-amino-3-(4-hydoxyphenyl)propanamide</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>TYC</Id>
			<Name>L-TYROSINAMIDE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0099</Id>
			<Name>L-tyrosine amide</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00108</Id>
			<Name>L-tyrosine amide</Name>
		</CrossReference>
		<Formula>C 9 H 11 N 2 O 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">TYC</Id>
				<Terminal>C</Terminal>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry-->
	<Entry>
		<Id>0049</Id>
		<Description>A protein modification that effectively converts an L-valine residue to L-valine amide.</Description>
		<SystematicName>(S)-2-amino-3-methylbutanamide</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>VLM</Id>
			<Name>VALINYLAMINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0100</Id>
			<Name>L-valine amide</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00109</Id>
			<Name>L-valine amide</Name>
		</CrossReference>
		<Formula>C 5 H 11 N 2 O 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">VLM</Id>
				<Terminal>C</Terminal>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0050</Id>
		<Description>A protein modification that effectively converts an L-cysteine residue to L-cysteine methyl ester.</Description>
		<SystematicName>methyl (2R)-2-amino-3-sulfanylpropanoate</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>CMT</Id>
			<Name>O-METHYLCYSTEINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0105</Id>
			<Name>L-cysteine methyl ester</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00114</Id>
			<Name>L-cysteine methyl ester</Name>
		</CrossReference>
		<Formula>C 4 H 8 N 1 O 2 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CMT</Id>
				<Terminal>C</Terminal>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0051</Id>
		<Description>A protein modification that effectively converts an L-cysteine residue to S-palmitoyl-L-cysteine.</Description>
		<SystematicName>(R)-2-amino-3-(hexadecanoylsulfanyl)propanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>P1L</Id>
			<Name>S-PALMITOYL-L-CYSTEINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0106</Id>
			<Name>S-palmitoyl-L-cysteine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00115</Id>
			<Name>S-palmitoyl-L-cysteine</Name>
		</CrossReference>
		<Formula>C 19 H 35 N 1 O 2 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">P1L</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0052</Id>
		<Description>A protein modification that effectively converts an L-cysteine residue to S-palmitoyl-L-cysteine.</Description>
		<SystematicName>(R)-2-amino-3-(hexadecanoylsulfanyl)propanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0106</Id>
			<Name>S-palmitoyl-L-cysteine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00115</Id>
			<Name>S-palmitoyl-L-cysteine</Name>
		</CrossReference>
		<Formula>C 19 H 35 N 1 O 2 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="Ligand" label="2">
				<Id source="PDBCC">PLM</Id>
			</Component>
			<Bond>
				<Atom component="1">SG</Atom>
				<Atom component="2">C1</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry>
	<Entry>
		<Id>0053</Id>
		<Description>A protein modification that effectively converts an L-lysine residue to N6-carboxy-L-lysine.</Description>
		<SystematicName>(S)-2-amino-6-(carboxyamino)hexanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>KCX</Id>
			<Name>LYSINE NZ-CARBOXYLIC ACID</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0114</Id>
			<Name>N6-carboxy-L-lysine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00123</Id>
			<Name>N6-carboxy-L-lysine</Name>
		</CrossReference>
		<Formula>C 7 H 12 N 2 O 3</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">KCX</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0054</Id>
		<Description>A protein modification that effectively converts an L-lysine residue to N6-1-carboxyethyl-L-lysine.</Description>
		<SystematicName>(S,S)-2-amino-6-(1-carboxyethyl)aminohexanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>MCL</Id>
			<Name>NZ-(1-CARBOXYETHYL)-LYSINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0115</Id>
			<Name>N6-1-carboxyethyl-L-lysine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00124</Id>
			<Name>N6-1-carboxyethyl-L-lysine</Name>
		</CrossReference>
		<Formula>C 9 H 16 N 2 O 3</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">MCL</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0055</Id>
		<Description>A protein modification that effectively converts an L-lysine residue to N6-biotinyl-L-lysine.</Description>
		<SystematicName>(S)-2-amino-6-[5-((3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]aminohexanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0117</Id>
			<Name>N6-biotinyl-L-lysine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00126</Id>
			<Name>N6-biotinyl-L-lysine</Name>
		</CrossReference>
		<Formula>C 16 H 26 N 4 O 3 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">LYS</Id>
			</Component>
			<Component type="Ligand" label="2">
				<Id source="PDBCC">BTN</Id>
			</Component>
			<Bond>
				<Atom component="1">NZ</Atom>
				<Atom component="2">C11</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry>
	<Entry>
		<Id>0056</Id>
		<Description>A protein modification that effectively crosslinks an L-glutamine residue and an L-lysine residue by an isopeptide bond with the formation of N6-(L-isoglutamyl)-L-lysine and the release of ammonia.</Description>
		<SystematicName>(S,S)-2-amino-6-[(4-amino-4-carboxybutanoyl)amino]hexanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0124</Id>
			<Name>N6-(L-isoglutamyl)-L-lysine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00133</Id>
			<Name>N6-(L-isoglutamyl)-L-lysine (Gln)</Name>
		</CrossReference>
		<Formula>C 11 H 17 N 3 O 3</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">LYS</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">GLN</Id>
			</Component>
			<Bond>
				<Atom component="1">NZ</Atom>
				<Atom component="2">CD</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink2</Category>
	</Entry>
	<Entry>
		<Id>0057</Id>
		<Description>A protein modification that effectively crosslinks an L-glutamic acid residue and an L-lysine residue by an isopeptide bond to form N6-(L-isoglutamyl)-L-lysine.</Description>
		<SystematicName>(S,S)-2-amino-6-[(4-amino-4-carboxybutanoyl)amino]hexanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0124</Id>
			<Name>N6-(L-isoglutamyl)-L-lysine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:01484</Id>
			<Name>N6-(L-isoglutamyl)-L-lysine (Glu)</Name>
		</CrossReference>
		<Formula>C 11 H 17 N 3 O 3</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">LYS</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">GLU</Id>
			</Component>
			<Bond>
				<Atom component="1">NZ</Atom>
				<Atom component="2">CD</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink2</Category>
	</Entry>
	<Entry>
		<Id>0058</Id>
		<Description>A protein modification that effectively crosslinks an L-lysine residue and a glycine residue by an isopeptide bond to form N6-glycyl-L-lysine.</Description>
		<SystematicName>(S)-2-amino-6-[(aminoacetyl)amino]hexanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0125</Id>
			<Name>N6-glycyl-L-lysine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00134</Id>
			<Name>N6-glycyl-L-lysine</Name>
		</CrossReference>
		<Formula>C 8 H 14 N 3 O 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">LYS</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">GLY</Id>
				<Terminal>C</Terminal>
			</Component>
			<Bond>
				<Atom component="1">NZ</Atom>
				<Atom component="2">C</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink2</Category>
	</Entry>
	<Entry>
		<Id>0059</Id>
		<Description>A protein modification that effectively crosslinks an L-asparagine residue and a glycine residue by an isopeptide bond with formation of N-(L-isoaspartyl)glycine and the release of ammonia.</Description>
		<SystematicName>(S)-2-amino-4-(carboxymethyl)amino-4-oxobutanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0126</Id>
			<Name>N-(L-isoaspartyl)-glycine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00135</Id>
			<Name>N-(L-isoaspartyl)glycine</Name>
		</CrossReference>
		<Formula>C 6 H 7 N 2 O 3</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">GLY</Id>
				<Terminal>N</Terminal>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">ASN</Id>
			</Component>
			<Bond>
				<!--TODO: verify this-->
				<Atom component="1">N</Atom>
				<Atom component="2">CG</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink2</Category>
	</Entry>
	<Entry>
		<Id>0060</Id>
		<Description>A protein modification that effectively crosslinks L-aspartic acid and L-cysteine residues via an isopeptide bond to form N-(L-isoaspartyl)-L-cysteine.</Description>
		<SystematicName>(S)-2-amino-4-((R)-1-carboxy-2-sulfanylethyl)amino-4-oxobutanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0216</Id>
			<Name>N-(L-isoaspartyl)-L-cysteine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00221</Id>
			<Name>N-(L-isoaspartyl)-L-cysteine</Name>
		</CrossReference>
		<Formula>C 7 H 9 N 2 O 3 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CYS</Id>
				<Terminal>N</Terminal>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">ASP</Id>
			</Component>
			<Bond>
				<Atom component="1">N</Atom>
				<Atom component="2">CG</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink2</Category>
	</Entry>
	<Entry>
		<Id>0061</Id>
		<Description>A protein modification that effectively crosslinks an L-asparagine residue and an L-lysine residue by an isopeptide bond with the formation of N6-(L-isoaspartyl)-L-lysine and the release of ammonia.</Description>
		<SystematicName>(S,S)-2-amino-6-[(3-amino-3-carboxypropanoyl)amino]hexanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0294</Id>
			<Name>N6-(L-isoaspartyl)-L-lysine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00299</Id>
			<Name>N6-(L-isoaspartyl)-L-lysine</Name>
		</CrossReference>
		<Formula>C 10 H 15 N 3 O 3</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">LYS</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">ASN</Id>
			</Component>
			<Bond>
				<Atom component="1">NZ</Atom>
				<Atom component="2">CG</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink2</Category>
	</Entry>
	<Entry>
		<Id>0062</Id>
		<Description>A protein modification that effectively crosslinks an L-glutamic acid residue and a glycine residue by an isopeptide bond to form N-(L-isoglutamyl)-glycine.</Description>
		<SystematicName>(S)-2-amino-5-(carboxymethyl)amino-5-oxopentanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0360</Id>
			<Name>N-(L-isoglutamyl)-glycine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00365</Id>
			<Name>N-(L-isoglutamyl)-glycine</Name>
		</CrossReference>
		<Formula>C 7 H 9 N 2 O 3</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">GLU</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">GLY</Id>
				<Terminal>N</Terminal>
			</Component>
			<Bond>
				<!--TODO: verify this-->
				<Atom component="1">CD</Atom>
				<Atom component="2">N</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink2</Category>
	</Entry>
	<Entry>
		<Id>0063</Id>
		<Description>A protein modification that effectively crosslinks an L-lysine residue and an L-threonine residue by an isopeptide bond to form N6-(L-threonyl)-L-lysine.</Description>
		<SystematicName>(2S)-2-amino-6-([(2S,3R)-2-amino-3-hydroxybutanoyl]amino)hexanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0440</Id>
			<Name>N6-(L-threonyl)-L-lysine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00924</Id>
			<Name>N6-(L-threonyl)-L-lysine</Name>
		</CrossReference>
		<Formula>C 10 H 18 N 3 O 3</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">LYS</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">THR</Id>
			</Component>
			<Bond>
				<!--TODO: verify this-->
				<Atom component="1">NZ</Atom>
				<Atom component="2">C</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink2</Category>
	</Entry>
	<Entry>
		<Id>0064</Id>
		<Description>A protein modification that effectively converts an L-lysine residue to N6-lipoyl-L-lysine.</Description>
		<SystematicName>(S)-2-amino-6-[5-((R)-1,2-dithiolan-3-yl)pentanamido]hexanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0118</Id>
			<Name>N6-lipoyl-L-lysine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00127</Id>
			<Name>N6-lipoyl-L-lysine</Name>
		</CrossReference>
		<Formula>C 14 H 24 N 2 O 2 S 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">LYS</Id>
			</Component>
			<Component type="Ligand" label="2">
				<Id source="PDBCC">LPA</Id>
			</Component>
			<Bond>
				<!--TODO: verify this-->
				<Atom component="1">NZ</Atom>
				<Atom component="2">C1</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry>
	<Entry>
		<Id>0065</Id>
		<Description>A protein modification that effectively converts an L-lysine residue to N6-pyridoxal phosphate-L-lysine.</Description>
		<SystematicName>(S)-2-amino-6-[([3-hydroxy-2-methyl-5-phosphonooxymethylpyridin-4-yl]methylidene)amino]hexanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>LLP</Id>
			<Name>2-LYSINE(3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL-PYRIDIN-4-YLMETHANE)</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0119</Id>
			<Name>N6-pyridoxal phosphate-L-lysine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00128</Id>
			<Name>N6-pyridoxal phosphate-L-lysine</Name>
		</CrossReference>
		<Formula>C 14 H 20 N 3 O 6 P 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">LLP</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0066</Id>
		<Description>A protein modification that effectively converts an L-lysine residue to N6-retinylidene-L-lysine, the adduct of retinal.</Description>
		<SystematicName>(S)-2-amino-6-[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)-2,4,6,8-nonatetraenylidene]aminohexanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>LYR</Id>
			<Name>N~6~-[(2Z,4E,6E,8E)-3,7-DIMETHYL-9-(2,6,6-TRIMETHYLCYCLOHEX-1-EN-1-YL)NONA-2,4,6,8-TETRAENYL]LYSINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0120</Id>
			<Name>N6-retinylidene-L-lysine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00129</Id>
			<Name>N6-retinylidene-L-lysine</Name>
		</CrossReference>
		<Formula>C 26 H 38 N 2 O 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">LYR</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0067</Id>
		<Description>A protein modification that effectively converts an L-lysine residue to N6-retinylidene-L-lysine, the adduct of retinal.</Description>
		<SystematicName>(S)-2-amino-6-[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)-2,4,6,8-nonatetraenylidene]aminohexanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0120</Id>
			<Name>N6-retinylidene-L-lysine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00129</Id>
			<Name>N6-retinylidene-L-lysine</Name>
		</CrossReference>
		<Formula>C 26 H 38 N 2 O 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">LYS</Id>
			</Component>
			<Component type="Ligand" label="2">
				<Id source="PDBCC">RET</Id>
			</Component>
			<Bond>
				<Atom component="1">NZ</Atom>
				<Atom component="2">C15</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry>
	<Entry>
		<Id>0068</Id>
		<Description>A protein modification that effectively converts an L-lysine residue to L-allysine.</Description>
		<SystematicName>(S)-2-amino-6-oxohexanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0121</Id>
			<Name>L-allysine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00130</Id>
			<Name>L-allysine</Name>
		</CrossReference>
		<Formula>C 6 H 9 N 1 O 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">LYS</Id>
			</Component>
			<Component type="Ligand" label="2">
				<Id source="PDBCC">DO2</Id>
			</Component>
			<Bond>
				<Atom component="1">NZ</Atom>
				<Atom component="2">CE</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry>
	<Entry>
		<Id>0069</Id>
		<Description>A protein modification that effectively crosslinks an L-serine residue and an L-lysine residue to release water and form 2-amino-6-(2-amino-2-carboxyethylamino)hexanoic acid.</Description>
		<SystematicName>(2S)-2-amino-6-((2Xi)-2-amino-2-carboxyethylamino)hexanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0123</Id>
			<Name>L-lysinoalanine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00132</Id>
			<Name>L-lysinoalanine</Name>
		</CrossReference>
		<Formula>C 9 H 15 N 3 O 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">LYS</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">SER</Id>
			</Component>
			<Bond>
				<!--TODO: verify this-->
				<Atom component="1">NZ</Atom>
				<Atom component="2">CB</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink2</Category>
	</Entry>
	<Entry>
		<Id>0070</Id>
		<Description>A protein modification that effectively results from forming an adduct between a cysteine residue and the tetrapyrrole compound phycocyanobilin.</Description>
		<SystematicName>(2R,3R)-3-[(1R)-1-(((2R)-2-amino-2-carboxy)ethylsulfanyl)ethyl]-8,12-bis(2-carboxyethyl)-18-ethyl-2,7,13,17-tetramethyl-1,2,3,19,21,22,24-heptahydrobilin-1,19(21H,22H,24H)-dione</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0131</Id>
			<Name>S-phycocyanobilin-L-cysteine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00140</Id>
			<Name>S-phycocyanobilin-L-cysteine</Name>
		</CrossReference>
		<Formula>C 36 H 43 N 5 O 7 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="Ligand" label="2">
				<Id source="PDBCC">CYC</Id>
			</Component>
			<Bond>
				<Atom component="1">SG</Atom>
				<Atom component="2">CAC</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry>
	<Entry>
		<Id>0071</Id>
		<Description>A protein modification that effectively results from forming an adduct between a cysteine residue and the tetrapyrrole compound phycoerythrobilin.</Description>
		<SystematicName>(2S,3R,16R)-18-ethenyl-3-[(1R)-1-(((2R)-2-amino-2-carboxy)ethylsulfanyl)ethyl]-8,12-bis(2-carboxyethyl)-2,7,13,17-tetramethyl-2,3,15,16-tetrahydrobilin-1,19(21H,22H,24H)-dione</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0132</Id>
			<Name>S-phycoerythrobilin-L-cysteine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00141</Id>
			<Name>S-phycoerythrobilin-L-cysteine</Name>
		</CrossReference>
		<Formula>C 36 H 43 N 5 O 7 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="Ligand" label="2">
				<Id source="PDBCC">PEB</Id>
			</Component>
			<Bond>
				<!--TODO: verify this-->
				<Atom component="1">SG</Atom>
				<Atom component="2">CAA</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry>
	<!--Entry>
		<Id>0072</Id>
		<Description>A protein modification that effectively results from forming an adduct between two cysteine residues and the porphyrin compound heme b, (7,12-diethenyl-3,8,13,17-tetramethylporphyrin-2,18-dipropanoato)iron.</Description>
		<SystematicName>[7,12-bis((S)-1-[((R)-2-amino-2-carboxy)ethylsulfanyl]ethyl)-3,8,13,17-tetramethyl-21H,23H-porphine-2,18-bis(2-carboxyethyl)-N21,N22,N23,N24]-ferrate</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0134</Id>
			<Name>heme-bis-L-cysteine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00143</Id>
			<Name>heme-bis-L-cysteine</Name>
		</CrossReference>
		<Formula>C 40 Fe 1 H 42 N 6 O 6 S 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Bond>
				<Atom component="1"></Atom>
				<Atom component="2"></Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink2</Category>
	</Entry-->
	<Entry>
		<Id>0073</Id>
		<Description>A protein modification that effectively converts four L-cysteine residues iron atom to tetrakis-L-cysteinyl iron.</Description>
		<SystematicName>tetrakis(cysteinato)-1kappaS,2kappaS,3kappaS,4kappaS-iron</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0136</Id>
			<Name>tetrakis-L-cysteinyl iron</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00145</Id>
			<Name>tetrakis-L-cysteinyl iron</Name>
		</CrossReference>
		<Formula>C 12 Fe 1 H 16 N 4 O 4 S 4</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="3">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="4">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="Ligand" label="5">
				<Id source="PDBCC">FE</Id>
			</Component>
			<Bond>
				<Atom component="1">SG</Atom>
				<Atom component="5">FE</Atom>
			</Bond>
			<Bond>
				<Atom component="2">SG</Atom>
				<Atom component="5">FE</Atom>
			</Bond>
			<Bond>
				<Atom component="3">SG</Atom>
				<Atom component="5">FE</Atom>
			</Bond>
			<Bond>
				<Atom component="4">SG</Atom>
				<Atom component="5">FE</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink4</Category>
	</Entry>
	<Entry>
		<Id>0074</Id>
		<Description>A protein modification that effectively converts four L-cysteine residues and a four-iron four-sulfur cluster to tetrakis-L-cysteinyl tetrairon tetrasulfide.</Description>
		<SystematicName>tetrakis(cysteinato)-1kappaS,2kappaS,3kappaS,4kappaS-tetra-mu3-sulfido-tetrahedro-tetrairon</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0140</Id>
			<Name>tetrakis-L-cysteinyl tetrairon tetrasulfide</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00149</Id>
			<Name>tetrakis-L-cysteinyl tetrairon tetrasulfide</Name>
		</CrossReference>
		<Formula>C 12 Fe 4 H 16 N 4 O 4 S 8</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="3">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="4">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="Ligand" label="5">
				<Id source="PDBCC">FS4</Id>
			</Component>
			<Bond>
				<Atom component="1">SG</Atom>
				<Atom component="5">FE1</Atom>
			</Bond>
			<Bond>
				<Atom component="2">SG</Atom>
				<Atom component="5">FE2</Atom>
			</Bond>
			<Bond>
				<Atom component="3">SG</Atom>
				<Atom component="5">FE3</Atom>
			</Bond>
			<Bond>
				<Atom component="4">SG</Atom>
				<Atom component="5">FE4</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink4</Category>
	</Entry>
	<Entry>
		<Id>0075</Id>
		<Description>A protein modification that effectively converts an L-cysteine residue, an L-histidine residue, homocitric acid and a one-molybdenum seven-iron nine-sulfur cluster to L-cysteinyl-L-histidino-homocitryl molybdenum heptairon nonasulfide.</Description>
		<SystematicName></SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0141</Id>
			<Name>L-cysteinyl-L-histidino-homocitryl molybdenum heptairon nonasulfide</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00150</Id>
			<Name>L-cysteinyl-L-histidino-homocitryl molybdenum heptairon nonasulfide</Name>
		</CrossReference>
		<Formula>C 16 Fe 7 H 18 Mo 1 N 4 O 9 S 10</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">HIS</Id>
			</Component>
			<Component type="Ligand" label="3">
				<Id source="PDBCC">CFM</Id>
			</Component>
			<Component type="Ligand" label="4">
				<Id source="PDBCC">HCA</Id>
			</Component>
			<Bond>
				<Atom component="1">SG</Atom>
				<Atom component="3">FE1</Atom>
			</Bond>
			<Bond>
				<Atom component="2">ND1</Atom>
				<Atom component="3">MO1</Atom>
			</Bond>
			<Bond>
				<Atom component="3">MO1</Atom>
				<Atom component="4">O5</Atom>
			</Bond>
			<Bond>
				<Atom component="3">MO1</Atom>
				<Atom component="4">O7</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink2</Category>
	</Entry>
	<Entry>
		<Id>0076</Id>
		<Description>A protein modification that effectively converts an L-cysteine residue, an L-histidine residue, homocitric acid and a one-molybdenum seven-iron nine-sulfur cluster to L-cysteinyl-L-histidino-homocitryl molybdenum heptairon nonasulfide.</Description>
		<SystematicName></SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0141</Id>
			<Name>L-cysteinyl-L-histidino-homocitryl molybdenum heptairon nonasulfide</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00150</Id>
			<Name>L-cysteinyl-L-histidino-homocitryl molybdenum heptairon nonasulfide</Name>
		</CrossReference>
		<Formula>C 16 Fe 7 H 18 Mo 1 N 4 O 9 S 10</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">HIS</Id>
			</Component>
			<Component type="Ligand" label="3">
				<Id source="PDBCC">CFN</Id>
			</Component>
			<Component type="Ligand" label="4">
				<Id source="PDBCC">HCA</Id>
			</Component>
			<Bond>
				<Atom component="1">SG</Atom>
				<Atom component="3">FE1</Atom>
			</Bond>
			<Bond>
				<Atom component="2">ND1</Atom>
				<Atom component="3">MO1</Atom>
			</Bond>
			<Bond>
				<Atom component="3">MO1</Atom>
				<Atom component="4">O5</Atom>
			</Bond>
			<Bond>
				<Atom component="3">MO1</Atom>
				<Atom component="4">O7</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink2</Category>
	</Entry>
	<Entry>
		<Id>0077</Id>
		<Description>modification from UniMod and Resid</Description>
		<SystematicName>8-amino-2-(2-amino-2-carboxyethyl)sulfanyl-4,5a,6,9,10,11,11a-heptahydro-4-(phosphoric acid)methyl-2,2,10-trioxo-pteridino[6,7-5,6]pyrano[3,4-4,3][1,2,5]molybdadithiolene</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0142</Id>
			<Name>L-cysteinyl molybdopterin</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00151</Id>
			<Name>L-cysteinyl molybdopterin</Name>
		</CrossReference>
		<Formula>C 13 H 16 Mo 1 N 6 O 9 P 1 S 3</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="Ligand" label="2">
				<Id source="PDBCC">MTQ</Id>
			</Component>
			<Bond>
				<Atom component="1">SG</Atom>
				<Atom component="2">MOM1</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry>
	<Entry>
		<Id>0078</Id>
		<Description>A protein modification that effectively converts an L-cysteine residue to S'-(8alpha-FAD)-L-cystine.</Description>
		<SystematicName>(R)-2-amino-3-[8alpha-riboflavin 5'-(trihydrogen diphosphate) 5'->5'-ester with adenosine]sulfanylpropanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0143</Id>
			<Name>S-(8alpha-FAD)-L-cysteine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00152</Id>
			<Name>S-(8alpha-FAD)-L-cysteine</Name>
		</CrossReference>
		<Formula>C 30 H 36 N 10 O 16 P 2 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="Ligand" label="2">
				<Id source="PDBCC">FAD</Id>
			</Component>
			<Bond>
				<Atom component="1">SG</Atom>
				<Atom component="2">C8M</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry>
	<Entry>
		<Id>0079</Id>
		<Description>A protein modification that effectively converts an L-histidine residue to 3'-(8alpha-FAD)-L-histidine.</Description>
		<SystematicName>(S)-2-amino-3-(3-[8alpha-riboflavin 5'-(trihydrogen diphosphate) 5'->5'-ester with adenosine]imidazol-4-yl)propanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0144</Id>
			<Name>3'-(8alpha-FAD)-L-histidine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00153</Id>
			<Name>3'-(8alpha-FAD)-L-histidine</Name>
		</CrossReference>
		<Formula>C 33 H 38 N 12 O 16 P 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">HIS</Id>
			</Component>
			<Component type="Ligand" label="2">
				<Id source="PDBCC">FAD</Id>
			</Component>
			<Bond>
				<Atom component="1">ND1</Atom>
				<Atom component="2">C8M</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry>
	<Entry>
		<Id>0080</Id>
		<Description>A protein modification that effectively converts an L-tyrosine residue to O4'-(8alpha-FAD)-L-tyrosine.</Description>
		<SystematicName>(S)-2-amino-3-(4-[8alpha-riboflavin 5'-(trihydrogen diphosphate) 5'->5'-ester with adenosine]oxyphenyl)propanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0145</Id>
			<Name>O4'-(8alpha-FAD)-L-tyrosine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00154</Id>
			<Name>O4'-(8alpha-FAD)-L-tyrosine</Name>
		</CrossReference>
		<Formula>C 36 H 40 N 10 O 17 P 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">TYR</Id>
			</Component>
			<Component type="Ligand" label="2">
				<Id source="PDBCC">FAD</Id>
			</Component>
			<Bond>
				<Atom component="1">OH</Atom>
				<Atom component="2">C8M</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry>
	<Entry>
		<Id>0081</Id>
		<Description>A protein modification that effectively converts an L-tyrosine residue to an L-2',4',5'-topaquinone.</Description>
		<SystematicName>(S)-2-amino-3-(5-hydroxy-2,5-cyclohexadien-1,4-dion-2-yl)propanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>TPQ</Id>
			<Name>5-(2-CARBOXY-2-AMINOETHYL)-2-HYDROXY-1,4-BENZOQUINONE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0147</Id>
			<Name>L-2',4',5'-topaquinone</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00156</Id>
			<Name>oxidation of tyrosine to L-2',4',5'-topaquinone</Name>
		</CrossReference>
		<Formula>C 9 H 7 N 1 O 4</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">TPQ</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0082</Id>
		<Description>A protein modification that effectively converts an L-tryptophan residue to an L-tryptophan quinone.</Description>
		<SystematicName>(S)-3-(2-amino-2-carboxyethyl)-6,7-indolinedione</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>TRQ</Id>
			<Name>2-AMINO-3-(6,7-DIOXO-6,7-DIHYDRO-1H-INDOL-3-YL)-PROPIONIC ACID</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0148</Id>
			<Name>L-tryptophyl quinone</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00157</Id>
			<Name>oxidation of tryptophan to L-tryptophyl quinone</Name>
		</CrossReference>
		<Formula>C 11 H 8 N 2 O 3</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">TRQ</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0083</Id>
		<Description>A protein modification that effectively cross-links two L-tryptophan residues by a carbon-carbon bond to form 4'-(L-tryptophan)-L-tryptophyl quinone.</Description>
		<SystematicName>(S,S)-3-(2-amino-2-carboxyethyl)-4-[3-(2-amino-2-carboxyethyl)-1H-indol-2-yl]-6,7-indolinedione</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0149</Id>
			<Name>4'-(L-tryptophan)-L-tryptophyl quinone</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00158</Id>
			<Name>4'-(L-tryptophan)-L-tryptophyl quinone</Name>
		</CrossReference>
		<Formula>C 22 H 16 N 4 O 4</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">TRP</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">TRP</Id>
			</Component>
			<Bond>
				<Atom component="1">CD1</Atom>
				<Atom component="2">CE3</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink2</Category>
	</Entry>
	<Entry>
		<Id>0084</Id>
		<Description>A protein modification that effectively converts an L-serine residue to O-phosphopantetheine-L-serine.</Description>
		<SystematicName>(2R)-4-((2S)-2-amino-2-carboxyethyl)phosphonato-2-hydroxy-N-[3-(2-sulfanylethyl)amino-3-oxopropyl]-3,3-dimethylbutanamide</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0150</Id>
			<Name>O-phosphopantetheine-L-serine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00159</Id>
			<Name>O-phosphopantetheine-L-serine</Name>
		</CrossReference>
		<Formula>C 14 H 26 N 3 O 8 P 1 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">SER</Id>
			</Component>
			<Component type="Ligand" label="2">
				<Id source="PDBCC">PNS</Id>
			</Component>
			<Bond>
				<Atom component="1">OG</Atom>
				<Atom component="2">P24</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry>
	<Entry>
		<Id>0085</Id>
		<Description>A protein modification that effectively converts an L-asparagine residue to O-(N-acetylaminogalactosyl)-L-threonine.</Description>
		<SystematicName>(2S,3R)-2-amino-3-(alpha-D-2-acetamido-2-deoxygalactopyranosyloxy)butanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>GTH</Id>
			<Name>3-O-GLUCOPYRANOSYL-THREONINE-[2-DEOXY-2-ACETAMIDO-GLUCOPYRANOSIDE]</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0155</Id>
			<Name>O-(N-acetylamino)galactosyl-L-threonine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00164</Id>
			<Name></Name>
		</CrossReference>
		<Formula>C 12 H 20 N 2 O 7</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">GTH</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<!--Entry>
		<Id>0086</Id>
		<Description>A protein modification that effectively substitutes an L-tyrosine residue with 3',3'',5'-triiodo-L-thyronine.</Description>
		<SystematicName>(S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0177</Id>
			<Name>3',3'',5'-triiodo-L-thyronine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00186</Id>
			<Name>3',3'',5'-triiodo-L-thyronine</Name>
		</CrossReference>
		<Formula>C 15 H 10 I 3 N 1 O 3</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">TYR</Id>
			</Component>
			<Component type="Ligand" label="2">
				<Id source="PDBCC">T3</Id>
			</Component>
			<Bond>
				<Atom component="1"></Atom>
				<Atom component="2"></Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry>
	<Entry>
		<Id>0087</Id>
		<Description>A protein modification that effectively substitutes an L-tyrosine residue with L-thyroxine.</Description>
		<SystematicName>(S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0178</Id>
			<Name>L-thyroxine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00187</Id>
			<Name>L-thyroxine</Name>
		</CrossReference>
		<Formula>C 15 H 9 I 4 N 1 O 3</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">TYR</Id>
			</Component>
			<Component type="Ligand" label="2">
				<Id source="PDBCC">T44</Id>
			</Component>
			<Bond>
				<Atom component="1"></Atom>
				<Atom component="2"></Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry-->
	<Entry>
		<Id>0088</Id>
		<Description>A protein modification that effectively converts an L-tryptophan residue to L-6'-bromotryptophan.</Description>
		<SystematicName>(S)-2-amino-3-(6-bromo-1H-indol-3-yl)propanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>BTR</Id>
			<Name>6-BROMO-TRYPTOPHAN</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0179</Id>
			<Name>L-6'-bromotryptophan</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00188</Id>
			<Name>L-6'-bromotryptophan</Name>
		</CrossReference>
		<Formula>Br 1 C 11 H 9 N 2 O 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">BTR</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0089</Id>
		<Description>A protein modification that effectively converts a source amino acid residue to dehydroalanine.</Description>
		<SystematicName>2-aminopropenoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>DHA</Id>
			<Name>2-AMINO-ACRYLIC ACID</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0181</Id>
			<Name>dehydroalanine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:01168</Id>
			<Name>dehydroalanine</Name>
		</CrossReference>
		<Formula>C 3 H 3 N 1 O 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">DHA</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
		<Comment>This modification occurs on SER or TYR</Comment>
	</Entry>
	<Entry>
		<Id>0090</Id>
		<Description>A protein modification that effectively converts L-tyrosine to (Z)-2,3-didehydrotyrosine.</Description>
		<SystematicName>(Z)-2-amino-3-(4-hydoxyphenyl)propenoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>CRQ</Id>
			<Name>[2-(3-CARBAMOYL-1-IMINO-PROPYL)-4-(4-HYDROXY-BENZYLIDENE)-5-OXO-4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0183</Id>
			<Name>(Z)-2,3-didehydrotyrosine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00191</Id>
			<Name>(Z)-2,3-didehydrotyrosine</Name>
		</CrossReference>
		<Formula>C 9 H 7 N 1 O 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CRQ</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
		<Comment>CRQ has two modifications: RESID:AA0183 and RESID:AA0189</Comment>
	</Entry>
	<Entry>
		<Id>0091</Id>
		<Description>A protein modification that effectively crosslinks an L-glutamine residue and a glycine residue to form 2-imino-glutamine 5-imidazolinone glycine.</Description>
		<SystematicName>2-(3-carbamoyl-1-imino-propyl)-1-carboxymethyl-1-imidazolin-5-one</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>CRQ</Id>
			<Name>[2-(3-CARBAMOYL-1-IMINO-PROPYL)-4-(4-HYDROXY-BENZYLIDENE)-5-OXO-4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0189</Id>
			<Name>2-imino-glutamine 5-imidazolinone glycine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00197</Id>
			<Name>2-imino-glutamine 5-imidazolinone glycine</Name>
		</CrossReference>
		<Formula>C16 H16 N4 O5</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CRQ</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink1</Category>
		<Comment>CRQ has two modifications: RESID:AA0183 and RESID:AA0189</Comment>
	</Entry>
	<Entry>
		<Id>0092</Id>
		<Description>A protein modification that effectively converts L-tyrosine to (Z)-2,3-didehydrotyrosine.</Description>
		<SystematicName>(Z)-2-amino-3-(4-hydoxyphenyl)propenoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>CRO</Id>
			<Name>{2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-(4-hydroxybenzylidene)-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0183</Id>
			<Name>(Z)-2,3-didehydrotyrosine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00191</Id>
			<Name>(Z)-2,3-didehydrotyrosine</Name>
		</CrossReference>
		<Formula>C 9 H 7 N 1 O 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CRO</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
		<Comment>CRO has two modifications: RESID:AA0183 and RESID:AA0184</Comment>
	</Entry>
	<Entry>
		<Id>0093</Id>
		<Description>A protein modification that effectively crosslinks an L-serine residue and a glycine residue to form L-serine 5-imidazolinone glycine.</Description>
		<SystematicName>2-[(R)-1-amino-2-hydroxyethyl]-1-carboxymethyl-1-imidazolin-5-one</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>CRO</Id>
			<Name>{2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-(4-hydroxybenzylidene)-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0184</Id>
			<Name>L-serine 5-imidazolinone glycine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00192</Id>
			<Name>L-serine 5-imidazolinone glycine</Name>
		</CrossReference>
		<Formula>C 5 H 6 N 2 O 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CRO</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink1</Category>
		<Comment>CRO has two modifications: RESID:AA0183 and RESID:AA0184</Comment>
	</Entry>
	<Entry>
		<Id>0094</Id>
		<Description>A protein modification that effectively converts a source amino acid residue to L-oxoalanine.</Description>
		<SystematicName>(S)-2-amino-3-oxopropanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>FGL</Id>
			<Name>2-AMINOPROPANEDIOIC ACID</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0185</Id>
			<Name>L-3-oxoalanine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:01169</Id>
			<Name>L-3-oxoalanine</Name>
		</CrossReference>
		<Formula>C 3 H 3 N 1 O 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">FGL</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
		<Comment>This modification occurs on SER or CYS</Comment>
	</Entry>
	<Entry>
		<Id>0095</Id>
		<Description>A protein modification that effectively converts a source amino acid residue to D-alanine.</Description>
		<SystematicName>(R)-2-aminopropanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>DAL</Id>
			<Name>D-ALANINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0191</Id>
			<Name>D-alanine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00862</Id>
			<Name>D-alanine</Name>
		</CrossReference>
		<Formula>C 3 H 5 N 1 O 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">DAL</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<!--Entry> what are they attached to
		<Id>0096</Id>
		<Description>A protein modification that effectively converts an L-serine residue to D-alanine.</Description>
		<SystematicName>(R)-2-aminopropanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0191</Id>
			<Name>D-alanine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00858</Id>
			<Name>D-alanine (Ser)</Name>
		</CrossReference>
		<Formula>C 3 H 5 N 1 O 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">SER</Id>
			</Component>
			<Component type="Ligand" label="2">
				<Id source="PDBCC">DAL</Id>
			</Component>
			<Bond>
				<Atom component="1"></Atom>
				<Atom component="2"></Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry>
	<Entry>
		<Id>0097</Id>
		<Description>A protein modification that effectively converts an L-alanine residue to D-alanine.</Description>
		<SystematicName>(R)-2-aminopropanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0191</Id>
			<Name>D-alanine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00198</Id>
			<Name>D-alanine (Ala)</Name>
		</CrossReference>
		<Formula>C 3 H 5 N 1 O 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">ALA</Id>
			</Component>
			<Component type="Ligand" label="2">
				<Id source="PDBCC">DAL</Id>
			</Component>
			<Bond>
				<Atom component="1"></Atom>
				<Atom component="2"></Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry-->
	<Entry>
		<Id>0098</Id>
		<Description>A protein modification that effectively converts an L-isoleucine residue to a D-allo-isoleucine.</Description>
		<SystematicName>(2R,3S)-2-amino-3-methylpentanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>DIL</Id>
			<Name>D-ISOLEUCINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0192</Id>
			<Name>D-allo-isoleucine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00199</Id>
			<Name>D-allo-isoleucine</Name>
		</CrossReference>
		<Formula>C 6 H 11 N 1 O 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">DIL</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0099</Id>
		<Description>A protein modification that effectively converts an L-asparagine residue to D-asparagine.</Description>
		<SystematicName>(R)-2-amino-4-butanediamic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>DSG</Id>
			<Name>D-ASPARAGINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0196</Id>
			<Name>D-asparagine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00203</Id>
			<Name>D-asparagine</Name>
		</CrossReference>
		<Formula>C 4 H 6 N 2 O 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">DSG</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0100</Id>
		<Description>A protein modification that effectively converts an L-tryptophan residue to D-tryptophan.</Description>
		<SystematicName>(R)-2-amino-3-(1H-indol-3-yl)propanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>DTR</Id>
			<Name>D-TRYPTOPHAN</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0198</Id>
			<Name>D-tryptophan</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00205</Id>
			<Name>D-tryptophan</Name>
		</CrossReference>
		<Formula>C 11 H 10 N 2 O 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">DTR</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0101</Id>
		<Description>A protein modification that effectively converts an L-threonine residue to D-allo-threonine.</Description>
		<SystematicName>(2R,3R)-2-amino-3-hydroxybutanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>DTH</Id>
			<Name>D-THREONINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0199</Id>
			<Name>D-threonine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00863</Id>
			<Name>D-allo-threonine</Name>
		</CrossReference>
		<Formula>C 4 H 7 N 1 O 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">DTH</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0102</Id>
		<Description>A protein modification that effectively converts an L-valine residue to D-valine.</Description>
		<SystematicName>(R)-2-amino-3-methylbutanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>DVA</Id>
			<Name>D-VALINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0200</Id>
			<Name>D-valine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00705</Id>
			<Name>D-valine</Name>
		</CrossReference>
		<Formula>C 5 H 9 N 1 O 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">DVA</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0103</Id>
		<Description>A protein modification that effectively monooxygenates an L-cysteine residue to L-cysteine sulfenic acid.</Description>
		<SystematicName>(R)-2-amino-2-carboxyethanesulfenic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>CSO</Id>
			<Name>S-HYDROXYCYSTEINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0205</Id>
			<Name>L-cysteine sulfenic acid</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00210</Id>
			<Name>L-cysteine sulfenic acid</Name>
		</CrossReference>
		<Formula>C 3 H 5 N 1 O 2 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CSO</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0104</Id>
		<Description>A protein modification that effectively monooxygenates an L-cysteine residue to L-cysteine sulfenic acid.</Description>
		<SystematicName>(R)-2-amino-2-carboxyethanesulfenic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>CSX</Id>
			<Name>S-OXY CYSTEINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0205</Id>
			<Name>L-cysteine sulfenic acid</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00210</Id>
			<Name>L-cysteine sulfenic acid</Name>
		</CrossReference>
		<Formula>C 3 H 5 N 1 O 2 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CSX</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0105</Id>
		<Description>A protein modification that effectively crosslinks an L-cysteine residue and a glycine residue by a thioester bond to form S-glycyl-L-cysteine.</Description>
		<SystematicName>(2R)-2-amino-3-[(aminoacetyl)sulfanyl]propanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0206</Id>
			<Name>S-glycyl-L-cysteine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00211</Id>
			<Name>S-glycyl-L-cysteine</Name>
		</CrossReference>
		<Formula>C 5 H 7 N 2 O 2 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">GLY</Id>
				<Terminal>C</Terminal>
			</Component>
			<Bond>
				<!--TODO: verify this-->
				<Atom component="1">SG</Atom>
				<Atom component="2">C</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink2</Category>
	</Entry>
	<Entry>
		<Id>0106</Id>
		<Description>A protein modification that effectively converts an L-cysteine residue to S-4-hydroxycinnamyl-L-cysteine.</Description>
		<SystematicName>(S,E)-2-amino-3-[3-(4-hydroxyphenyl)propenoylsulfanyl]propanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0207</Id>
			<Name>S-4-hydroxycinnamyl-L-cysteine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00212</Id>
			<Name>S-4-hydroxycinnamyl-L-cysteine</Name>
		</CrossReference>
		<Formula>C 12 H 11 N 1 O 3 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="Ligand" label="2">
				<Id source="PDBCC">HC4</Id>
			</Component>
			<Bond>
				<Atom component="1">SG</Atom>
				<Atom component="2">C1</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry>
	<Entry>
		<Id>0107</Id>
		<Description>A protein modification that effectively converts an L-arginine residue to a 4-hydroxy-L-arginine.</Description>
		<SystematicName>(2S,4Xi)-2-amino-5-[(diaminomethylidene)amino]-4-hydroxypentanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>ARO</Id>
			<Name>C-GAMMA-HYDROXY ARGININE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0215</Id>
			<Name>4-hydroxy-L-arginine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00220</Id>
			<Name>4-hydroxy-L-arginine</Name>
		</CrossReference>
		<Formula>C 6 H 12 N 4 O 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">ARO</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0108</Id>
		<Description>A protein modification that effectively converts an L-cysteine residue to S-(6-FMN)-L-cysteine.</Description>
		<SystematicName>(R)-2-amino-3-[6-riboflavin 5'-dihydrogen phosphate]sulfanylpropanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0220</Id>
			<Name>S-(6-FMN)-L-cysteine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00225</Id>
			<Name>S-(6-FMN)-L-cysteine</Name>
		</CrossReference>
		<Formula>C 20 H 24 N 5 O 10 P 1 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="Ligand" label="2">
				<Id source="PDBCC">FMN</Id>
			</Component>
			<Bond>
				<!--TODO: verify this-->
				<Atom component="1">SG</Atom>
				<Atom component="2">C6</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry>
	<Entry>
		<Id>0109</Id>
		<Description>A protein modification that effectively converts an L-histidine residue to 1'-(8alpha-FAD)-L-histidine.</Description>
		<SystematicName>(S)-2-amino-3-(1-[8alpha riboflavin 5'-(trihydrogen diphosphate) 5'->5'-ester with adenosine]imidazol-4-yl)propanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0221</Id>
			<Name>1'-(8alpha-FAD)-L-histidine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00226</Id>
			<Name>1'-(8alpha-FAD)-L-histidine</Name>
		</CrossReference>
		<Formula>C 33 H 38 N 12 O 16 P 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">HIS</Id>
			</Component>
			<Component type="Ligand" label="2">
				<Id source="PDBCC">FAD</Id>
			</Component>
			<Bond>
				<Atom component="1">NE2</Atom>
				<Atom component="2">C8M</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry>
	<Entry>
		<Id>0110</Id>
		<Description>A protein modification that effectively crosslinks an L-lysine residue and 5'-phosphoguanosine through a phosphoramide ester bond to form N6-(phospho-5'-guanosine)-L-lysine.</Description>
		<SystematicName>(S)-2-amino-6-(5'-guanosine phosphonamino)hexanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>GPL</Id>
			<Name>LYSINE GUANOSINE-5'-MONOPHOSPHATE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0228</Id>
			<Name>N6-(phospho-5'-guanosine)-L-lysine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00233</Id>
			<Name>N6-(phospho-5'-guanosine)-L-lysine</Name>
		</CrossReference>
		<Formula>C 16 H 24 N 7 O 8 P 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">GPL</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0111</Id>
		<Description>A protein modification that effectively converts an L-cysteine residue to S-nitrosyl-L-cysteine.</Description>
		<SystematicName>(2R)-2-amino-3-nitrososulfanyl-propanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>SNC</Id>
			<Name>S-NITROSO-CYSTEINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0230</Id>
			<Name>S-nitrosyl-L-cysteine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00235</Id>
			<Name>S-nitrosyl-L-cysteine</Name>
		</CrossReference>
		<Formula>C 3 H 4 N 2 O 2 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">SNC</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0112</Id>
		<Description>A protein modification that effectively cross-links an L-lysine residue and an L-tyrosine residue by a carbon-nitrogen bond to form 5'-(N6-L-lysine)-L-topaquinone.</Description>
		<SystematicName>1-[(S)-5-amino-5-carboxypentyl]amino-2-[(S)-2-amino-2-carboxyethyl]-2,6-cyclohexadien-4,5-dione</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0233</Id>
			<Name>2'-(L-lys-N6-yl)-L-4',5'-topaquinone</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00238</Id>
			<Name>5'-(N6-L-lysine)-L-topaquinone</Name>
		</CrossReference>
		<Formula>C 15 H 17 N 3 O 4</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">TPQ</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">LYS</Id>
			</Component>
			<Bond>
				<!--TODO: verify this-->
				<Atom component="1">C2</Atom>
				<Atom component="2">NZ</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink2</Category>
	</Entry>
	<Entry>
		<Id>0113</Id>
		<Description>A protein modification that effectively converts an L-cysteine residue to S-methyl-L-cysteine.</Description>
		<SystematicName>(R)-2-amino-3-(methylsulfanyl)propanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>SMC</Id>
			<Name>S-METHYLCYSTEINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0234</Id>
			<Name>S-methyl-L-cysteine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00239</Id>
			<Name>S-methyl-L-cysteine</Name>
		</CrossReference>
		<Formula>C 4 H 7 N 1 O 1 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">SMC</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0114</Id>
		<Description>A protein modification that effectively cross-links an L-histidine residue and an L-tyrosine residue by a carbon-nitrogen bond to form 3-(3'-L-histidyl)-L-tyrosine.</Description>
		<SystematicName>(2S,3R)-2-amino-3-(5-[(2S)-2-amino-2-carboxyethyl]-1H-imidazol-1-yl)-3-(4-hydroxyphenyl)propanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0250</Id>
			<Name>3-(3'-L-histidyl)-L-tyrosine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00255</Id>
			<Name>3-(3'-L-histidyl)-L-tyrosine</Name>
		</CrossReference>
		<Formula>C 15 H 14 N 4 O 3</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">HIS</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">TYR</Id>
			</Component>
			<Bond>
				<!--TODO: verify this-->
				<Atom component="1">ND1</Atom>
				<Atom component="2">CB</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink2</Category>
	</Entry>
	<Entry>
		<Id>0115</Id>
		<Description>A protein modification that dioxygenates an L-methionine residue to L-methionine sulfone.</Description>
		<SystematicName>(S)-2-amino-4-(methylsulfonyl)butanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>OMT</Id>
			<Name>S-DIOXYMETHIONINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0251</Id>
			<Name>L-methionine sulfone</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00256</Id>
			<Name>L-methionine sulfone</Name>
		</CrossReference>
		<Formula>C 5 H 9 N 1 O 3 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">OMT</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0116</Id>
		<Description>A protein modification that effectively converts an L-cysteine residue to dipyrrolylmethanemethyl-L-cysteine.</Description>
		<SystematicName>3-[5-[4-(2-carboxy)ethyl-3-carboxymethyl-1-pyrrol-2-yl]methyl-4-(2-carboxy)ethyl-3-carboxymethyl-1-pyrrol-2-yl]methylthio-2-aminopropanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0252</Id>
			<Name>dipyrrolylmethanemethyl-L-cysteine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00257</Id>
			<Name>dipyrrolylmethanemethyl-L-cysteine</Name>
		</CrossReference>
		<Formula>C 23 H 27 N 3 O 9 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="Ligand" label="2">
				<Id source="PDBCC">DPM</Id>
			</Component>
			<Bond>
				<Atom component="1">SG</Atom>
				<Atom component="2">CHA</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry>
	<Entry>
		<Id>0117</Id>
		<Description>A protein modification that effectively results from forming an adduct between a cysteine residue and the tetrapyrrole compound phycoviolobilin.</Description>
		<SystematicName>(4S)-3-[(1R)-1-(((2R)-2-amino-2-carboxy)ethylsulfanyl)ethyl]-8,12-bis(2-carboxyethyl)-18-ethyl-4,5-dihydro-2,7,13,17-tetramethyl-(21H,22H,24H)-biladiene-bc-1,19-dione</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0258</Id>
			<Name>S-phycoviolobilin-L-cysteine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00263</Id>
			<Name>S-phycoviolobilin-L-cysteine</Name>
		</CrossReference>
		<Formula>C 36 H 43 N 5 O 7 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="Ligand" label="2">
				<Id source="PDBCC">PVN</Id>
			</Component>
			<Bond>
				<Atom component="1">SG</Atom>
				<Atom component="2">C31</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry>
	<Entry>
		<Id>0118</Id>
		<Description>A protein modification that effectively results from forming an adduct between two cysteine residues and the tetrapyrrole compound phycourobilin.</Description>
		<SystematicName>3,18-bis(1-[(R)-2-amino-2-carboxyethyl]sulfanylethyl)-8,12-bis(2-carboxyethyl)-2,7,13,17-tetramethyl-4,5,15,16-tetrahydro-(21H,22H,24H)-bilene-b-1,19(4H,16H)-dione</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0260</Id>
			<Name>phycourobilin-bis-L-cysteine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00265</Id>
			<Name>phycourobilin-bis-L-cysteine</Name>
		</CrossReference>
		<Formula>C 39 H 48 N 6 O 8 S 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="Ligand" label="3">
				<Id source="PDBCC">CYB</Id>
			</Component>
			<Bond>
				<!--TODO: verify this-->
				<Atom component="1">SG</Atom>
				<Atom component="3">CAB</Atom>
			</Bond>
			<Bond>
				<!--TODO: verify this-->
				<Atom component="2">SG</Atom>
				<Atom component="3">CBC</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink2</Category>
	</Entry>
	<Entry>
		<Id>0119</Id>
		<Description>A protein modification that effectively dioxygenates an L-cysteine residue to L-cysteine sulfinic acid.</Description>
		<SystematicName>(R)-2-amino-2-carboxyethanesulfinic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>CSD</Id>
			<Name>3-SULFINOALANINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0262</Id>
			<Name>(R)-2-amino-2-carboxyethanesulfinic acid</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00267</Id>
			<Name>cysteine-S,S-dioxide</Name>
		</CrossReference>
		<Formula>C 3 H 5 N 1 O 3 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CSD</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0120</Id>
		<Description>A protein modification that effectively dioxygenates an L-cysteine residue to L-cysteine sulfinic acid.</Description>
		<SystematicName>(R)-2-amino-2-carboxyethanesulfinic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>CSW</Id>
			<Name>CYSTEINE-S-DIOXIDE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0262</Id>
			<Name>(R)-2-amino-2-carboxyethanesulfinic acid</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00267</Id>
			<Name>cysteine-S,S-dioxide</Name>
		</CrossReference>
		<Formula>C 3 H 5 N 1 O 3 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CSW</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0121</Id>
		<Description>A protein modification that effectively converts an L-serine residue to O-(sn-1-glycerophosphoryl)-L-serine.</Description>
		<SystematicName>(2S)-2-amino-3-[(2Xi)-2,3-dihydroxypropyl]phosphonoxypropanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0264</Id>
			<Name>O-(sn-1-glycerophosphoryl)-L-serine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00269</Id>
			<Name>O-(sn-1-glycerophosphoryl)-L-serine</Name>
		</CrossReference>
		<Formula>C 6 H 12 N 1 O 7 P 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">SER</Id>
			</Component>
			<Component type="Ligand" label="2">
				<Id source="PDBCC">OPE</Id>
			</Component>
			<Bond>
				<!--TODO: verify this-->
				<Atom component="1">CB</Atom>
				<Atom component="2">O3</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>Attachment</Category>
	</Entry>
	<Entry>
		<Id>0122</Id>
		<Description>A protein modification that effectively converts a glycine residue to an internal 1-thioglycine.</Description>
		<SystematicName>aminoethanethioic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>GL3</Id>
			<Name>THIOGLYCIN</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0265</Id>
			<Name>1-thioglycine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00270</Id>
			<Name>1-thioglycine (internal)</Name>
		</CrossReference>
		<Formula>C 2 H 3 N 1 O 0 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">GL3</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
		<Comments>There are two entries in PSI-MOD MOD:00270 and MOD:01623, corresponding to internal and terminal.</Comments>
	</Entry>
	<Entry>
		<Id>0123</Id>
		<Description>A protein modification that effectively results from forming an adduct between two cysteine residues, the C-3' of a tyrosine residue, and the porphyrin compound heme b, (7,12-diethenyl-3,8,13,17-tetramethylporphyrin-2,18-dipropanoato)iron.</Description>
		<SystematicName>(10S,11S)-[7,12-bis((S)-1-[((R)-2-amino-2-carboxy)ethylsulfanyl]ethyl)-10-(2-hydroxy-5-[(S)-2-amino-2-carboxy]ethylphenyl)-3,8,13,17-tetramethyl-21H,23H-10,11-dihydroporphine-2,18-bis(2-carboxyethyl)-N21,N22,N23,N24]-ferrate</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0266</Id>
			<Name>heme P460-bis-L-cysteine-L-tyrosine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00271</Id>
			<Name>heme P460-bis-L-cysteine-L-tyrosine</Name>
		</CrossReference>
		<Formula>C 49 Fe 1 H 51 N 7 O 8 S 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="3">
				<Id source="PDBCC">TYR</Id>
			</Component>
			<Component type="Ligand" label="4">
				<Id source="PDBCC">HEC</Id>
			</Component>
			<Bond>
				<Atom component="1">SG</Atom>
				<Atom component="4">CAB</Atom>
			</Bond>
			<Bond>
				<Atom component="2">SG</Atom>
				<Atom component="4">CAC</Atom>
			</Bond>
			<Bond>
				<!--TODO: verify this-->
				<Atom component="3">CE2</Atom>
				<Atom component="4">CHC</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink3</Category>
	</Entry>
	<Entry>
		<Id>0124</Id>
		<Description>A protein modification that effectively results from forming an adduct between two cysteine residues, a lysine residue, and the porphyrin compound heme b, (7,12-diethenyl-3,8,13,17-tetramethylporphyrin-2,18-dipropanoato)iron.</Description>
		<SystematicName>(19S,20S)-[7,12-bis((S)-1-[((R)-2-amino-2-carboxy)ethylsulfanyl]ethyl)-20-([(S)-5-amino-5-carboxypentyl]amino)-3,8,13,17-tetramethyl-21H,23H-19,20-dihydroporphine-2,18-bis(2-carboxyethyl)-N21,N22,N23,N24]-ferrate</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0271</Id>
			<Name>heme P460-bis-L-cysteine-L-lysine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00276</Id>
			<Name>heme P460-bis-L-cysteine-L-lysine</Name>
		</CrossReference>
		<Formula>C 46 Fe 1 H 54 N 8 O 7 S 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="3">
				<Id source="PDBCC">LYS</Id>
			</Component>
			<Component type="Ligand" label="4">
				<Id source="PDBCC">HEC</Id>
			</Component>
			<Bond>
				<Atom component="1">SG</Atom>
				<Atom component="4">CAB</Atom>
			</Bond>
			<Bond>
				<Atom component="2">SG</Atom>
				<Atom component="4">CAC</Atom>
			</Bond>
			<Bond>
				<Atom component="3">NZ</Atom>
				<Atom component="4">CHA</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink3</Category>
	</Entry>
	<Entry>
		<Id>0125</Id>
		<Description>A protein modification that effectively converts an L-cysteine residue to L-cysteine persulfide.</Description>
		<SystematicName>(R)-2-amino-3-disulfanylpropanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>CSS</Id>
			<Name>S-MERCAPTOCYSTEINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0269</Id>
			<Name>L-cysteine persulfide</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00274</Id>
			<Name>L-cysteine persulfide</Name>
		</CrossReference>
		<Formula>C 3 H 5 N 1 O 1 S 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CSS</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0126</Id>
		<Description>A protein modification that effectively cross-links an L-histidine residue and an L-tyrosine residue by a carbon-nitrogen bond to form 3'-(1'-L-histidyl)-L-tyrosine.</Description>
		<SystematicName>(2S)-2-amino-3-[1-(5-[(2S)-2-amino-2-carboxyethyl]-2-hydroxyphenyl)-1H-imidazol-4-yl]propanoic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0270</Id>
			<Name>3'-(1'-L-histidyl)-L-tyrosine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00275</Id>
			<Name>3'-(1'-L-histidyl)-L-tyrosine</Name>
		</CrossReference>
		<Formula>C 15 H 14 N 4 O 3</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">HIS</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">TYR</Id>
			</Component>
			<Bond>
				<!--TODO: verify this-->
				<Atom component="1">NE2</Atom>
				<Atom component="2">CE1</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink2</Category>
	</Entry>
	<Entry>
		<Id>0127</Id>
		<Description>A protein modification that effectively converts an L-glutamine residue to 2-methyl-L-glutamine.</Description>
		<SystematicName>(S)-2-amino-2-methylpentanediamic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>MGN</Id>
			<Name>2-METHYL-GLUTAMINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0273</Id>
			<Name>2-methyl-L-glutamine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00278</Id>
			<Name>2-methyl-L-glutamine</Name>
		</CrossReference>
		<Formula>C 6 H 10 N 2 O 2</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">MGN</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0128</Id>
		<Description>A protein modification that effectively converts an L-cysteine residue to S-selenyl-L-cysteine.</Description>
		<SystematicName>(R)-2-amino-3-(selanylsulfanyl)propanoic acid</SystematicName>
		<CrossReference>
			<Source>PDBCC</Source>
			<Id>CSZ</Id>
			<Name>S-SELANYL CYSTEINE</Name>
		</CrossReference>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0277</Id>
			<Name>S-selanyl-L-cysteine</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00282</Id>
			<Name>S-selenyl-L-cysteine</Name>
		</CrossReference>
		<Formula>C 3 H 5 N 1 O 1 S 1 Se 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CSZ</Id>
			</Component>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>ModifiedResidue</Category>
	</Entry>
	<Entry>
		<Id>0129</Id>
		<Description>A protein modification that effectively results from forming an adduct between an aspartic acid residue, a glutamic acid residue, a methionine residue (forming a sulfonium ether), and the porphyrin compound heme b, (7,12-diethenyl-3,8,13,17-tetramethylporphyrin-2,18-dipropanoato)iron.</Description>
		<SystematicName>(19S,20S)-[7,12-bis((S)-1-[((R)-2-amino-2-carboxy)ethylsulfanyl]ethyl)-20-([(S)-5-amino-5-carboxypentyl]amino)-3,8,13,17-tetramethyl-21H,23H-19,20-dihydroporphine-2,18-bis(2-carboxyethyl)-N21,N22,N23,N24]-ferrate</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0280</Id>
			<Name>dihydroxyheme-L-aspartate ester-L-glutamate ester-L-methionine sulfonium</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00285</Id>
			<Name>dihydroxyheme-L-aspartate ester-L-glutamate ester-L-methionine sulfonium</Name>
		</CrossReference>
		<Formula>C 48 Fe 1 H 50 N 7 O 11 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">ASP</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">GLU</Id>
			</Component>
			<Component type="AminoAcid" label="3">
				<Id source="PDBCC">MET</Id>
			</Component>
			<Component type="Ligand" label="4">
				<Id source="PDBCC">HEM</Id>
			</Component>
			<Bond>
				<Atom component="1">OD2</Atom>
				<Atom component="4">CMD</Atom>
			</Bond>
			<Bond>
				<Atom component="2">OE2</Atom>
				<Atom component="4">CMB</Atom>
			</Bond>
			<Bond>
				<Atom component="3">SD</Atom>
				<Atom component="4">CBB</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink3</Category>
	</Entry>
	<Entry>
		<Id>0130</Id>
		<Description>A protein modification that effectively doubly cross-links an L-glutamic acid residue and an L-tyrosine residue with a carbon-carbon bond and a carbon-nitrogen bond to form pyrroloquinoline quinone.</Description>
		<SystematicName>4,5-dihydro-4,5-dioxo-1H-pyrrolo[2,3-5,6]quinoline-2,7,9-tricarboxylic acid</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0283</Id>
			<Name>pyrroloquinoline quinone</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00288</Id>
			<Name>pyrroloquinoline quinone</Name>
		</CrossReference>
		<Formula>C 14 H 6 N 2 O 8</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">GLU</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">TYR</Id>
			</Component>
			<Component type="Ligand" label="3">
				<Id source="PDBCC">PQQ</Id>
			</Component>
			<Bond>
				<!--TODO: verify this-->
				<Atom component="1">CG</Atom>
				<Atom component="3">N1</Atom>
			</Bond>
			<Bond>
				<!--TODO: verify this-->
				<Atom component="2">OH</Atom>
				<Atom component="3">C8</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink3</Category>
	</Entry>
	<Entry>
		<Id>0131</Id>
		<Description>A protein modification that effectively converts three L-cysteine residues, an L-histidine residue and a four-iron four-sulfur cluster to tris-L-cysteinyl L-N1'-histidino tetrairon tetrasulfide.</Description>
		<SystematicName>tetra-mu3-sulfidotris(S-cysteinyliron)(N1'-histidinoiron)</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0284</Id>
			<Name>tris-L-cysteinyl L-N1'-histidino tetrairon tetrasulfide</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00289</Id>
			<Name>tris-L-cysteinyl L-N1'-histidino tetrairon tetrasulfide</Name>
		</CrossReference>
		<Formula>C 15 Fe 4 H 18 N 6 O 4 S 7</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="3">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="4">
				<Id source="PDBCC">HIS</Id>
			</Component>
			<Component type="Ligand" label="5">
				<Id source="PDBCC">FS4</Id>
			</Component>
			<Bond>
				<Atom component="1">SG</Atom>
				<Atom component="5">FE1,FE2,FE3,FE4</Atom>
			</Bond>
			<Bond>
				<Atom component="2">SG</Atom>
				<Atom component="5">FE1,FE2,FE3,FE4</Atom>
			</Bond>
			<Bond>
				<Atom component="3">SG</Atom>
				<Atom component="5">FE1,FE2,FE3,FE4</Atom>
			</Bond>
			<Bond>
				<!--TODO: verify this-->
				<Atom component="4">NE2</Atom>
				<Atom component="5">FE1,FE2,FE3,FE4</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink4</Category>
		<Comment>FS4 is symmentric. Any FE could be linked to HIS.</Comment>
	</Entry>
	<Entry>
		<Id>0132</Id>
		<Description>A protein modification that effectively converts three L-cysteine residues, an L-histidine residue and a four-iron four-sulfur cluster to tris-L-cysteinyl L-N3'-histidino tetrairon tetrasulfide.</Description>
		<SystematicName>tetra-mu3-sulfidotris(S-cysteinyliron)(N3'-histidinoiron)</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0285</Id>
			<Name>tris-L-cysteinyl L-N3'-histidino tetrairon tetrasulfide</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00290</Id>
			<Name>tris-L-cysteinyl L-N3'-histidino tetrairon tetrasulfide</Name>
		</CrossReference>
		<Formula>C 15 Fe 4 H 18 N 6 O 4 S 7</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="3">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="4">
				<Id source="PDBCC">HIS</Id>
			</Component>
			<Component type="Ligand" label="5">
				<Id source="PDBCC">FS4</Id>
			</Component>
			<Bond>
				<Atom component="1">SG</Atom>
				<Atom component="5">FE1,FE2,FE3,FE4</Atom>
			</Bond>
			<Bond>
				<Atom component="2">SG</Atom>
				<Atom component="5">FE1,FE2,FE3,FE4</Atom>
			</Bond>
			<Bond>
				<Atom component="3">SG</Atom>
				<Atom component="5">FE1,FE2,FE3,FE4</Atom>
			</Bond>
			<Bond>
				<!--TODO: verify this-->
				<Atom component="4">ND1</Atom>
				<Atom component="5">FE1,FE2,FE3,FE4</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink4</Category>
		<Comment>FS4 is symmentric. Any FE could be linked to HIS.</Comment>
	</Entry>
	<Entry>
		<Id>0133</Id>
		<Description>A protein modification that effectively converts three L-cysteine residues, an L-aspartic acid residue and a four-iron four-sulfur cluster to tris-L-cysteinyl L-aspartato tetrairon tetrasulfide.</Description>
		<SystematicName>tetra-mu3-sulfidotris(S-cysteinyliron)(O4-aspartatoiron)</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0286</Id>
			<Name>tris-L-cysteinyl L-aspartato tetrairon tetrasulfide</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00291</Id>
			<Name>tris-L-cysteinyl L-aspartato tetrairon tetrasulfide</Name>
		</CrossReference>
		<Formula>C 13 Fe 4 H 16 N 4 O 6 S 7</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="3">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="4">
				<Id source="PDBCC">ASP</Id>
			</Component>
			<Component type="Ligand" label="5">
				<Id source="PDBCC">FS4</Id>
			</Component>
			<Bond>
				<Atom component="1">SG</Atom>
				<Atom component="5">FE1,FE2,FE3,FE4</Atom>
			</Bond>
			<Bond>
				<Atom component="2">SG</Atom>
				<Atom component="5">FE1,FE2,FE3,FE4</Atom>
			</Bond>
			<Bond>
				<Atom component="3">SG</Atom>
				<Atom component="5">FE1,FE2,FE3,FE4</Atom>
			</Bond>
			<Bond>
				<!--TODO: verify this-->
				<Atom component="4">OD2</Atom>
				<Atom component="5">FE1,FE2,FE3,FE4</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink4</Category>
		<Comment>FS4 is symmentric. Any FE could be linked to ASP.</Comment>
	</Entry>
	<Entry>
		<Id>0134</Id>
		<Description>A protein modification that effectively converts three L-cysteine residues, an L-serine residue and a four-iron four-sulfur cluster to tris-L-cysteinyl L-serinyl tetrairon tetrasulfide.</Description>
		<SystematicName>tetra-mu3-sulfidotris(S-cysteinyliron)(O3-serinyliron)</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0288</Id>
			<Name>tris-L-cysteinyl L-serinyl tetrairon tetrasulfide</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00293</Id>
			<Name>tris-L-cysteinyl L-serinyl tetrairon tetrasulfide</Name>
		</CrossReference>
		<Formula>C 12 Fe 4 H 16 N 4 O 5 S 7</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="3">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="4">
				<Id source="PDBCC">SER</Id>
			</Component>
			<Component type="Ligand" label="5">
				<Id source="PDBCC">FS4</Id>
			</Component>
			<Bond>
				<Atom component="1">SG</Atom>
				<Atom component="5">FE1,FE2,FE3,FE4</Atom>
			</Bond>
			<Bond>
				<Atom component="2">SG</Atom>
				<Atom component="5">FE1,FE2,FE3,FE4</Atom>
			</Bond>
			<Bond>
				<Atom component="3">SG</Atom>
				<Atom component="5">FE1,FE2,FE3,FE4</Atom>
			</Bond>
			<Bond>
				<!--TODO: verify this-->
				<Atom component="4">OG</Atom>
				<Atom component="5">FE1,FE2,FE3,FE4</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink4</Category>
		<Comment>FS4 is symmentric. Any FE could be linked to SER.</Comment>
	</Entry>
	<Entry>
		<Id>0135</Id>
		<Description>A protein modification that effectively converts two L-cysteine residues, an L-histidine residues, an L-serine residue and a four-iron four-sulfur cluster to bis-L-cysteinyl L-N3'-histidino L-serinyl tetrairon tetrasulfide.</Description>
		<SystematicName>tetra-mu3-sulfidobis(S-cysteinyliron)(N3'-histidinoiron)(O3-serinyliron)</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0289</Id>
			<Name>bis-L-cysteinyl L-N3'-histidino L-serinyl tetrairon tetrasulfide</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00294</Id>
			<Name>bis-L-cysteinyl L-N3'-histidino L-serinyl tetrairon tetrasulfide</Name>
		</CrossReference>
		<Formula>C 15 Fe 4 H 18 N 6 O 5 S 6</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">CYS</Id>
			</Component>
			<Component type="AminoAcid" label="3">
				<Id source="PDBCC">HIS</Id>
			</Component>
			<Component type="AminoAcid" label="4">
				<Id source="PDBCC">SER</Id>
			</Component>
			<Component type="Ligand" label="5">
				<Id source="PDBCC">FS4</Id>
			</Component>
			<Bond>
				<Atom component="1">SG</Atom>
				<Atom component="5">FE1,FE2,FE3,FE4</Atom>
			</Bond>
			<Bond>
				<Atom component="2">SG</Atom>
				<Atom component="5">FE1,FE2,FE3,FE4</Atom>
			</Bond>
			<Bond>
				<!--TODO: verify this-->
				<Atom component="3">ND1</Atom>
				<Atom component="5">FE1,FE2,FE3,FE4</Atom>
			</Bond>
			<Bond>
				<!--TODO: verify this-->
				<Atom component="4">OG</Atom>
				<Atom component="5">FE1,FE2,FE3,FE4</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink4</Category>
		<Comment>FS4 is symmentric. Any FE could be linked to SER and HIS.</Comment>
	</Entry>
	<Entry>
		<Id>0136</Id>
		<Description>A protein modification that effectively converts seven L-histidinine residues and a four-copper one-sulfur one-hydroxide cluster to heptakis-L-histidino tetracopper mu4-sulfide hydroxide.</Description>
		<SystematicName>mu4-sulfido bis(bis-N1'-histidino copper)(N1'-histidino-N3'-histidino copper)(N3'-histidino hydroxide copper)</SystematicName>
		<CrossReference>
			<Source>RESID</Source>
			<Id>AA0298</Id>
			<Name>heptakis-L-histidino tetracopper mu4-sulfide hydroxide</Name>
		</CrossReference>
		<CrossReference>
			<Source>PSI-MOD</Source>
			<Id>MOD:00303</Id>
			<Name>heptakis-L-histidino tetracopper mu4-sulfide hydroxide</Name>
		</CrossReference>
		<Formula>C 42 Cu 4 H 43 N 21 O 8 S 1</Formula>
		<Condition>
			<Component type="AminoAcid" label="1">
				<Id source="PDBCC">HIS</Id>
			</Component>
			<Component type="AminoAcid" label="2">
				<Id source="PDBCC">HIS</Id>
			</Component>
			<Component type="AminoAcid" label="3">
				<Id source="PDBCC">HIS</Id>
			</Component>
			<Component type="AminoAcid" label="4">
				<Id source="PDBCC">HIS</Id>
			</Component>
			<Component type="AminoAcid" label="5">
				<Id source="PDBCC">HIS</Id>
			</Component>
			<Component type="AminoAcid" label="6">
				<Id source="PDBCC">HIS</Id>
			</Component>
			<Component type="AminoAcid" label="7">
				<Id source="PDBCC">HIS</Id>
			</Component>
			<Component type="Ligand" label="8">
				<Id source="PDBCC">CUZ</Id>
			</Component>
			<Bond>
				<Atom component="1">NE2</Atom>
				<Atom component="8">CU1,CU2,CU3,CU4</Atom>
			</Bond>
			<Bond>
				<Atom component="2">NE2</Atom>
				<Atom component="8">CU1,CU2,CU3,CU4</Atom>
			</Bond>
			<Bond>
				<Atom component="3">NE2</Atom>
				<Atom component="8">CU1,CU2,CU3,CU4</Atom>
			</Bond>
			<Bond>
				<Atom component="4">NE2</Atom>
				<Atom component="8">CU1,CU2,CU3,CU4</Atom>
			</Bond>
			<Bond>
				<Atom component="5">NE2</Atom>
				<Atom component="8">CU1,CU2,CU3,CU4</Atom>
			</Bond>
			<Bond>
				<Atom component="6">ND1</Atom>
				<Atom component="8">CU1,CU2,CU3,CU4</Atom>
			</Bond>
			<Bond>
				<Atom component="7">ND1</Atom>
				<Atom component="8">CU1,CU2,CU3,CU4</Atom>
			</Bond>
		</Condition>
		<Occurrence>Natural</Occurrence>
		<Category>CrossLink7</Category>
	</Entry>
</ProteinModifications>